At the news
? NEUTRALIMPACT 4/10 8-K filed Sep 8, 2026 at 15:15 ET
Cycurion announced approximately $800,000 in annual contract spend from new commercial and public-health engagements, including a pharmaceutical AI Center of Excellence and a NACCHO award. This is the first public disclosure of these awards and represents a step in the company's stated strategy to expand beyond government into commercial healthcare and life sciences. However, at an $11M market cap, the absolute contract value is modest and does not provide financial details on revenue or profitability impact.
- Announced approximately $800,000 in aggregate annual contract spend from multiple new engagements.
- First public announcement of a pharmaceutical AI Center of Excellence engagement and a new NACCHO award.
- Engagements cover business continuity, cybersecurity assessments, program management, and AI operating capability.
- Company is building commercial healthcare and life-sciences work as a primary growth market while maintaining its government and public-safety franchise.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access